Al-Dawaa Medical Services Company (4163.SR)
SAR 78.9
(-0.63%)
SAR 78.9
(-0.63%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | 3.87 SAR | 7.8% |
| 2022 | 3.59 SAR | 27.76% |
| 2021 | 2.81 SAR | -3.1% |
| 2020 | 2.90 SAR | -99.75% |
| 2019 | 1166.02 SAR | 0.0% |
| 2018 | - SAR | 0.0% |
| 2017 | - SAR | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q1 | 1.12 SAR | 2.75% |
| 2024 Q2 | 1.13 SAR | 0.89% |
| 2023 Q2 | 1.05 SAR | 16.67% |
| 2023 Q1 | 0.90 SAR | -14.29% |
| 2023 FY | - SAR | 7.8% |
| 2023 Q4 | 1.09 SAR | 29.76% |
| 2023 Q3 | 0.84 SAR | -20.0% |
| 2022 Q4 | 1.05 SAR | 84.21% |
| 2022 Q3 | 0.57 SAR | -40.0% |
| 2022 Q2 | 0.95 SAR | -6.86% |
| 2022 Q1 | 1.02 SAR | 25.93% |
| 2022 FY | - SAR | 27.76% |
| 2021 Q3 | 0.45 SAR | -27.42% |
| 2021 Q2 | 0.62 SAR | -33.33% |
| 2021 Q4 | 0.81 SAR | 80.0% |
| 2021 FY | - SAR | -3.1% |
| 2021 Q1 | 0.93 SAR | 69.09% |
| 2020 Q2 | 3.32 SAR | 41.28% |
| 2020 FY | - SAR | -99.75% |
| 2020 Q4 | 0.55 SAR | 0.0% |
| 2020 Q3 | 0.55 SAR | -83.43% |
| 2020 Q1 | 2.35 SAR | 0.0% |
| 2019 FY | - SAR | 0.0% |
| 2018 FY | - SAR | 0.0% |
| 2017 FY | - SAR | 0.0% |
| Name | Eps | Eps Difference |
|---|---|---|
| Middle East Pharmaceutical Industries Co. | 3.29 SAR | -17.629% |
| Nahdi Medical Company | 6.87 SAR | 43.668% |
| Al-Razi Medical Co. | 0.45 SAR | -760.0% |
| Almujtama Alraida Medical Co. | 1.20 SAR | -222.5% |